Glenmark Life Sciences Limited (ALIVUS) Financial Statements

4 Followers

Glenmark Life Sciences Limited Financial Overview

Glenmark Life Sciences Limited's market cap is currently ₹127.34B. The company's EPS TTM is ₹22.173; its P/E ratio is 18.72; and it has a dividend yield of 0.56%. Glenmark Life Sciences Limited is scheduled to report earnings on April 23, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 22	Mar 21	Mar 19	Mar 18
Income Statement
Total Revenue	₹ 23.72B	₹ 21.23B	₹ 18.85B	₹ 14.05B	₹ 2.48M
Gross Profit	₹ 7.64B	₹ 10.80B	₹ 9.80B	₹ 7.79B	₹ 110.00K
Operating Income	₹ 6.24B	₹ 5.79B	₹ 5.62B	₹ 2.36B	₹ -130.00K
EBITDA	₹ 7.17B	₹ 6.31B	₹ 5.92B	₹ 2.48B	₹ 10.00K
Net Income	₹ 4.86B	₹ 4.19B	₹ 3.52B	₹ 2.93B	₹ -4.34M
Balance Sheet
Cash & Short-Term Investments	₹ 5.49B	₹ 5.17B	₹ 1.40B	₹ 78.48M	₹ 70.00K
Total Assets	₹ 34.11B	₹ 24.71B	₹ 19.97B	₹ 14.75B	₹ 850.00K
Total Debt	₹ 566.06M	₹ 28.84M	₹ 9.33B	₹ 210.00K	₹ 14.50M
Net Debt	₹ -144.56M	₹ -5.09B	₹ 8.17B	₹ -20.40M	₹ 14.43M
Total Liabilities	₹ 5.94B	₹ 4.17B	₹ 12.44B	₹ 13.87B	₹ 14.83M
Stockholders' Equity	₹ 28.17B	₹ 20.54B	₹ 7.53B	₹ 881.25M	₹ -13.98M
Cash Flow
Free Cash Flow	₹ 2.45B	₹ 4.65B	₹ 3.20B	₹ 10.27M	₹ -4.81M
Operating Cash Flow	₹ 4.11B	₹ 5.98B	₹ 3.88B	₹ 103.52M	₹ -4.81M
Investing Cash Flow	₹ -6.36B	₹ -1.22B	₹ -687.34M	₹ -89.14M	₹ 0.00
Financing Cash Flow	₹ -61.14M	₹ -787.96M	₹ -2.14B	₹ 5.35M	₹ 4.86M

Currency in INR

Glenmark Life Sciences Limited Earnings and Revenue History

Income Statement >

Glenmark Life Sciences Limited Debt to Assets

Balance Sheet >

Glenmark Life Sciences Limited Cash Flow

Cash Flow >

Glenmark Life Sciences Limited Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >